• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者黑质和尾状核中的脑啡肽能标志物。

Enkephalinergic markers in substantia nigra and caudate nucleus from Parkinsonian subjects.

作者信息

Llorens-Cortes C, Javoy-Agid F, Agid Y, Taquet H, Schwartz J C

出版信息

J Neurochem. 1984 Sep;43(3):874-7. doi: 10.1111/j.1471-4159.1984.tb12812.x.

DOI:10.1111/j.1471-4159.1984.tb12812.x
PMID:6086841
Abstract

Marked reductions in opiate receptor binding (-42%), "enkephalinase" activity (-39%), and Met5-enkephalin levels (-72%) accompanied the well-established dopamine depletion in the substantia nigra pars compacta of Parkinsonian subjects. In contrast, enkephalinergic markers were not significantly modified in caudate nucleus.

摘要

帕金森病患者黑质致密部中,明显的阿片受体结合减少(-42%)、“脑啡肽酶”活性降低(-39%)以及甲硫氨酸脑啡肽水平下降(-72%)与多巴胺耗竭密切相关。相比之下,尾状核中的脑啡肽能标志物没有显著改变。

相似文献

1
Enkephalinergic markers in substantia nigra and caudate nucleus from Parkinsonian subjects.帕金森病患者黑质和尾状核中的脑啡肽能标志物。
J Neurochem. 1984 Sep;43(3):874-7. doi: 10.1111/j.1471-4159.1984.tb12812.x.
2
Brain enkephalin receptors in Parkinson's disease.帕金森病中的脑内脑啡肽受体
J Neural Transm Suppl. 1983;19:163-71.
3
Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains.正常人和帕金森病患者中脑腹侧甲硫氨酸脑啡肽、多巴胺和去甲肾上腺素的微观结构
Brain Res. 1982 Mar 11;235(2):303-14. doi: 10.1016/0006-8993(82)91009-5.
4
[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.帕金森病和核上性麻痹中[3H]司哌罗宁结合、多巴胺及高香草酸浓度
Eur J Pharmacol. 1984 Mar 23;99(2-3):167-75. doi: 10.1016/0014-2999(84)90238-3.
5
Localization of opiate receptors in substantia nigra evidence by lesion studies.通过损伤研究对黑质中阿片受体的定位证据
Neurosci Lett. 1979 May;12(2-3):165-70. doi: 10.1016/0304-3940(79)96056-7.
6
Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease.在Shy-Drager综合征和帕金森病患者中,人类尾状核、黑质及额叶皮质中[3H]螺哌隆结合的改变。
J Neurol Sci. 1979 Nov;43(3):429-37. doi: 10.1016/0022-510x(79)90021-2.
7
The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.人脑黑质。II. 帕金森病中含多巴胺神经元的丢失模式。
Brain. 1999 Aug;122 ( Pt 8):1437-48. doi: 10.1093/brain/122.8.1437.
8
Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset.MPTP 处理的普通狨猴纹状体和纹状体外多巴胺摄取位点的短期和长期变化。
Eur J Pharmacol. 1995 Apr 24;277(2-3):235-41. doi: 10.1016/0014-2999(95)00086-z.
9
Parkinson's disease: low density and presynaptic location of D3 dopamine receptors.帕金森病:D3多巴胺受体的低密度和突触前定位。
Brain Res. 1981 May 18;212(2):494-8. doi: 10.1016/0006-8993(81)90484-4.
10
Glycine receptors in the human substantia nigra as defined by [3H]strychnine binding.
J Neurochem. 1982 Mar;38(3):718-24. doi: 10.1111/j.1471-4159.1982.tb08690.x.

引用本文的文献

1
Neuromodulation in Parkinson's disease targeting opioid and cannabinoid receptors, understanding the role of NLRP3 pathway: a novel therapeutic approach.帕金森病中靶向阿片类和大麻素受体的神经调节,了解 NLRP3 通路的作用:一种新的治疗方法。
Inflammopharmacology. 2023 Aug;31(4):1605-1627. doi: 10.1007/s10787-023-01259-0. Epub 2023 Jun 15.
2
C-type natriuretic peptide in Parkinson's disease: reduced secretion and response to deprenyl.帕金森病中的 C 型利钠肽:分泌减少及对司来吉兰的反应性降低。
J Neural Transm (Vienna). 2014 Apr;121(4):371-8. doi: 10.1007/s00702-013-1123-9. Epub 2013 Dec 5.
3
Striatal preproenkephalin gene expression is upregulated in acute but not chronic parkinsonian monkeys: implications for the contribution of the indirect striatopallidal circuit to parkinsonian symptomatology.
纹状体前脑啡肽原基因表达在急性而非慢性帕金森病猴中上调:对间接纹状体苍白球回路在帕金森病症状学中作用的启示。
J Neurosci. 1999 Aug 1;19(15):6643-9. doi: 10.1523/JNEUROSCI.19-15-06643.1999.
4
Alterations in neuropeptides in aging and disease. Pathophysiology and potential for clinical intervention.衰老与疾病中神经肽的改变。病理生理学及临床干预潜力。
Drugs Aging. 1993 Sep-Oct;3(5):408-27. doi: 10.2165/00002512-199303050-00003.
5
Morphine, D-Pen2, D-Pen5 enkephalin and U50,488H differentially affect the locomotor activity and behaviours induced by quinpirole in guinea-pigs.吗啡、D-青霉胺2、D-青霉胺5脑啡肽和U50,488H对豚鼠中由喹吡罗诱导的运动活动和行为有不同影响。
Psychopharmacology (Berl). 1992;107(4):581-90. doi: 10.1007/BF02245274.